Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis

NCT04919954 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Diabetes
Wound Infection
ABSSSI
Healthy Volunteers

Interventions

DRUG: Tebipenem Pivoxil Hydrobromide

Sponsor

Hartford Hospital

Collaborators

[object Object]